GSK Investigational Site

Cypress, California 90630

0 studies enrolling now · 9 studies all time

What they study most

Asthma, Atherosclerosis, Dermatitis, Atopic, Idiopathic Pulmonary Fibrosis, Infection, Human Immunodeficiency Virus, Pulmonary Disease, Chronic Obstructive

Studies at this site

• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European Ancestry — Completed
• A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on Nintedanib — Completed
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive — Completed
• Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients — Completed
• Efficacy and Safety Study in Subjects With Asthma — Completed
• Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis — Completed
• Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects — Completed
• A Study To Determine The Effect Of SB-480848 On Asthma — Completed
• A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects — Completed